427
Propylthiouracil-induced hypothyroidism is associated with
increased tolerance of the isolated rat heart to
ischaemia-reperfusion
C Pantos, V Malliopoulou, I Mourouzis, K Sfakianoudis, S Tzeis,
P Doumba, C Xinaris, A D Cokkinos, H Carageorgiou,
D D Varonos and D V Cokkinos1
Department of Pharmacology, University of Athens, 75 Mikras Asias Avenue, 11527 Goudi, Athens, Greece
1
First Cardiology Department, Onassis Cardiac Surgery Center, 356 Sygrou Avenue, 17674 Kallithea, Athens, Greece
(Requests for offprints should be addressed to C Pantos; Email: cpantos@cc.uoa.gr)
Abstract
The present study investigated the response of the hypothyroid heart to ischaemia-reperfusion. Hypothyroidism
was induced in Wistar rats by oral administration of
propylthiouracil (0·05%) for 3 weeks (HYPO rats), while
normal animals (NORM) served as controls. Isolated
hearts from NORM and HYPO animals were perfused in
Langendorff mode and subjected to zero-flow global
ischaemia followed by reperfusion (I/R). Post-ischaemic
recovery of left ventricular developed pressure was
expressed as % of the initial value (LVDP%). Basal
expression of protein kinase C (PKC) and PKC and
phosphorylation of p46 and p54 c-jun NH2-terminal
kinases (JNKs) in response to I/R were assessed by
Western blotting. LVDP% was found to be significantly
higher in HYPO hearts than in NORM. At baseline,
PKC expression was 1·4-fold more in HYPO than in
NORM hearts, P,0·05, while PKC was not changed.
Furthermore, basal phospho-p54 and -p46 JNK levels
were 2·2- and 2·6-fold more in HYPO than in NORM
hearts, P,0·05. In response to I/R, in NORM hearts,
phospho-p54 and -p46 JNK levels were 5·5- and 6·0-fold
more as compared with the baseline values, P,0·05,
while they were not significantly altered in HYPO hearts.
HYPO hearts seem to display a phenotype of cardioprotection against ischaemia-reperfusion and this is associated
with basal PKC overexpression and attenuated JNK
activation after I/R.
Introduction
including myosin heavy chain isoforms and , sarcoplasmic reticulum calcium activated ATPase (SR Ca2+ ATPase), phospholamban, the -adrenergic receptor, adenylyl cyclase isoforms and various membrane ion channels
(Klein & Ojamaa 2001). Furthermore, recent research has
revealed that thyroid hormone can interfere with the
regulation of important intracellular signalling transduction
pathways (Fryer et al. 1998, Pantos et al. 2001, 2002a,
2003a) that are thought to be involved in protection
against ischaemia-reperfusion (I/R) (Speechly-Dick et al.
1994, Kawamura et al. 1998, Zhao et al. 1998, Pantos et al.
2000, 2001, Fryer et al. 2001). In fact, chronic administration of T4 results in changes in cardioprotective molecules such as protein kinase C (PKC) and mitogenactivated protein kinases (Fryer et al. 1998, Pantos et al.
2001, 2002a, 2003a) and this was shown to be associated
with increased post-ischaemic recovery of function (Buser
et al. 1990, Pantos et al. 2002a, 2003a,c).
On the basis of this evidence, thyroid hormone seems to
be an important regulator of cardiac performance as well as
Hypothyroidism is a common clinical condition with
various consequences on the cardiovascular system and has
been associated with increased cardiovascular morbidity
(Hak et al. 2000, Vanderpump et al. 2002). Furthermore,
circulating thyroid hormone levels have been demonstrated to decline (3,5,3 -triiodothyronine (T3) more and
to a lesser extent -thyroxine (T4)) in various conditions
such as acute myocardial infarction (Franklyn et al. 1984),
congestive heart failure (Hamilton et al. 1998) or diabetes
(Yue et al. 1998). Abnormal thyroid function also occurs
after cardiac surgery requiring cardiopulmonary bypass
(Bartkowski et al. 2002) or chronic administration of
amiodarone (Klein & Ojamaa 2001).
It has been long realized that the heart is one of the most
thyroid hormone-responsive tissues (Klein & Ojamaa
2001). In fact, thyroid hormone is shown to regulate
the transcription of various myocyte-specific genes that
encode important structural and regulatory proteins
Journal of Endocrinology (2003) 178, 427–435
Journal of Endocrinology (2003) 178, 427–435
0022–0795/03/0178–427 2003 Society for Endocrinology Printed in Great Britain
Online version via http://www.endocrinology.org
428
C PANTOS
and others · Hypothyroidism and heart tolerance to ischaemia-reperfusion
of the response of the heart to ischaemic stresses and
consequently one could anticipate that low thyroid
hormone states might lead to impaired myocardial
performance and increased susceptibility of the heart to
ischaemia. This hypothesis, although of clinical relevance,
has not been previously adequately explored. Therefore,
the present study investigated the response of the
isolated rat heart to I/R in an experimental model of
propylthiouracil-induced hypothyroidism.
difference between left ventricular peak systolic pressure
and LVEDP. LVDP and its positive and negative first
derivative (+dp/dt,dp/dt) were measured at the end of
the stabilization and reperfusion period respectively. Postischaemic cardiac function was assessed by the recovery of
LVDP which was expressed as % of the initial value
(LVDP%) and by LVEDP at 45 min of reperfusion.
Ischaemic contracture was assessed by measurement of the
observed increase in left ventricular pressure at various
time points during ischaemia.
Materials and Methods
Total protein preparation
Animals
Isolation of total protein content and Western blotting
have been performed as previously described (Pantos et al.
2001, 2002a, 2003a). Approximately 0·2 g frozen tissue
was homogenized in ice-cold Tris–sucrose buffer (0·35 M
sucrose, 10 mM Tris–HCl pH 7·5, 1 mM EDTA,
0·5 mM dithiothreitol, 0·1 mM phenylmethanesulfonyl
fluoride) with a Polytron homogenizer and the resulting
homogenate was centrifuged at 15 000 g for 20 min at
4 C. The supernatant, representing the total cell extract,
was used for immunoblotting. Protein concentrations were
determined by the bicinchoninic acid method using BSA
(Walker 1994).
Forty-two Wistar male rats, 270–320 g were used for this
study. The rats were handled in accordance with the
Guide for the Care and Use of Laboratory Animals
published by the US National Institutes of Health (NIH
Publication No 85–23, revised 1985). Anaesthesia was
achieved with i.p. injection of ketamine hydrochloric acid
(150 mg/kg).
Experimental hypothyroidism
Hypothyroidism was induced in rats by administration of
6-n-propyl-2-thiouracil in drinking water to a final concentration of 0·05% for 3 weeks (Cernohorsky et al. 1998,
Shenoy et al. 2001). These animals were designated as
HYPO. Untreated rats were used as controls and were
designated as NORM.
Isolated heart preparation
A non-ejecting isolated rat heart preparation was perfused
at constant coronary flow according to the Langendorff
technique, as previously described (Pantos et al. 2000,
2002b, 2003b). In this model, coronary flow per gram of
cardiac tissue was similar in all the experimental groups.
Rats were anaesthetized with i.p. injection of ketamine
hydrochloric acid and heparin (1000 IU/kg body weight)
was given i.v. before thoracotomy. The hearts were
perfused with oxygenated (95%O2/5%CO2) Krebs–
Henseleit buffer at a constant temperature of 37 C and
were paced at 320 bpm with a Harvard pacemaker. The
pacemaker was turned off during the period of ischaemia.
An intraventricular balloon allowed measurement of contractility under isovolumic conditions. Left ventricular
balloon volume was adjusted to produce an average initial
left ventricular end-diastolic pressure (LVEDP) of 6
mmHg in all groups and was held constant thereafter
throughout the experiment. Pressure signal was transferred
to a personal computer using data analysis software (IOX;
Emka Technologies, Paris, France). Cardiac function was
assessed by left ventricular peak systolic pressure and the
left ventricular developed pressure (LVDP), defined as the
Journal of Endocrinology (2003) 178, 427–435
SDS-PAGE and immunoblotting
After boiling for 5 min in Laemmli sample buffer, protein
aliquots (40 µg) were loaded onto 10% (w/v) acrylamide
gels and subjected to SDS-PAGE. After Western blotting,
filters were probed with specific antibodies against either
PKC or PKC (Transduction Laboratories, Lexington,
KY, USA, dilution 1:1000), or total c-jun NH2-terminal
kinases (JNKs) or dual phospho-JNKs (New England
Biolabs, Hitchin, Herts, UK, dilution 1:1000), or actin
(Sigma, 1:1000) overnight at 4 C and immunoreactivity
was detected by enhanced chemiluminescence. Immunoblots were quantified using the AlphaScan Imaging
Densitometer (Alpha Innotech Corporation, San Leaudro,
CA, USA). For comparisons between groups, five samples
from each group were loaded on the same gel. Optical
densities of PKC, PKC, dual phospho-JNKs and total
JNK immunoreactivity were expressed as a ratio of the
actin optical density to correct for slight variations in total
protein loading.
Experimental protocol
Hearts from NORM and HYPO rats were subjected
only to 20 min of stabilization, NORM-Base, n=5 and
HYPO-Base, n=5.
Hearts from NORM and HYPO rats were subjected to
20 min of stabilization, 20 min of zero-flow global
ischaemia and 45 min of reperfusion, NORM-20I/R,
n=8, and HYPO-20I/R, n=8. Since ischaemic contracture did not reach a plateau within 20 min of ischaemia,
www.endocrinology.org
Hypothyroidism and heart tolerance to ischaemia-reperfusion ·
Table 1 Initial body weight (BW1 in g), body weight after 3 weeks
of treatment (BW2 in g), left ventricular weight (LVW in mg), the
ratio of left ventricular weight to body weight (LVW/BW in mg/g),
T3 and T4 levels in plasma (nmol/l) for NORM and HYPO rats. The
values are means S.E.M.
BW1
BW2
LVW
LVW/BW2
T3
T4
HYPO
3057·9
3389·9
83127·7
2·40·05
0·870·04
52·502·63
3072·6
2689·1*
67520·2*
2·50·09
0·230·05*
19·970·38*
and others 429
Results
Thyroid hormones and alterations in animal body weight and
heart weight
Propylthiouracil administration resulted in a significant
decrease of thyroid hormone levels in plasma (Table 1).
Animal body weight and left ventricular weight were
significantly decreased in HYPO compared with NORM
rats (Table 1).
Group
NORM
C PANTOS
Basal and post-ischaemic cardiac function
*P<0·05 vs NORM.
hearts from NORM and HYPO animals were also
subjected to 20 min of stabilization, 30 min of
zero-flow global ischaemia and 45 min of reperfusion,
NORM-30I/R, n=8, and HYPO-30I/R, n=8.
Measurement of thyroid hormones
Plasma T4 and T3 quantitative measurements were performed by using 125I RIA kits obtained from DiaSorin,
Stillwater, MN, USA (CA 1535 M for T4 and CA 1541
for T3). T4 and T3 levels were expressed as nmol/l of
plasma.
Basal cardiac contractility was found to be significantly
reduced in HYPO as compared with NORM rats (Table
2). Post-ischaemic recovery of function was found to be
significantly improved in hearts from HYPO animals as
compared with NORM hearts after either 20 or 30 min of
ischaemia (Fig. 1; Table 2).
Ischaemic contracture profile
Profiles of ischaemic contracture are shown in Fig. 2.
Within 20 min of ischaemia, neither NORM nor HYPO
hearts reached a plateau, although HYPO hearts displayed
a significant attenuation of the rise of diastolic pressure.
Within 30 min of ischaemia, ischaemic contracture
reached a maximum at 25·31·4 min in NORM hearts,
while in HYPO hearts it did not reach a peak.
PKC and PKC protein expression at baseline
Statistics
Values are presented as means S.E.M. The unpaired t-test
and Mann–Whitney test were used for differences
between groups. A two-tailed test with a P value less than
0·05 was considered significant.
PKC protein expression at baseline was not different
between NORM and HYPO hearts, P.0·05. However,
PKC protein expression at baseline was 1·4-fold more
in HYPO-Base than in NORM-Base hearts, P,0·05
(Fig. 3).
Table 2 Left ventricular developed pressure (LVDP, mmHg), +dp/dt (mmHg/s) and dp/dt (mmHg/s) at the
end of the stabilization period for NORM and HYPO hearts as well as LVDP%, LVDP and left ventricular
end-diastolic pressure (LVEDP, mmHg) at 45 min of reperfusion (R) for NORM and HYPO hearts subjected to
20 or 30 min of ischaemia. I/R=ischaemia/reperfusion. The values are means S.E.M.
Group
LVDP (baseline)
+dp/dt (baseline)
dp/dt (baseline)
LVDP at 45 min R
LVEDP at 45 min R
LVDP%
NORM-20I/R
(n=8)
HYPO-20I/R
(n=8)
NORM-30I/R
(n=8)
HYPO-30I/R
(n=8)
129·34·5
5150280
2615112
80·16·5
52·85·6
60·65·1
103·82·3*
3417135*
185147*
96·33·6*
12·33·4*
93·14·1*
133·94·5
4476227
2461149
15·63·1
105·83·6
11·52·1
109·03·6**
3200259**
173185**
65·910·8**
36·07·7**
61·311·0**
*P<0·05 vs NORM-20I/R; **P<0·05 vs NORM-30I/R.
www.endocrinology.org
Journal of Endocrinology (2003) 178, 427–435
430
C PANTOS
and others · Hypothyroidism and heart tolerance to ischaemia-reperfusion
Figure 1 Post-ischaemic recovery of function, LVDP%, (upper
panel) and left ventricular end-diastolic pressure at 45 min of
reperfusion, LVEDP45, (bottom panel) in normal hearts (NORM)
and hearts from hypothyroid rats (HYPO) subjected to 20 or
30 min of ischaemia. (Bar= S.E.M.)
Phosphorylation of p54 and p46 JNKs after I/R
The levels of phospho-p54 and -p46 JNKs were found to
be 2·2- and 2·6-fold more in HYPO-Base than in
NORM-Base hearts respectively, P,0·05. After I/R, the
levels of phospho-p54 and -p46 JNKs were increased 5·5and 6·0-fold respectively in NORM-20I/R as compared
with NORM-Base hearts, P,0·05. On the contrary,
there was not a significant increase in the levels of the
phospho-JNKs in HYPO-20I/R as compared with
HYPO-Base. The levels of phospho-p54 and -p46 JNKs
were 1·8- and 2·2-fold less in HYPO-20I/R hearts as
compared with NORM-20I/R hearts respectively,
P,0·05 (Fig. 4).
Discussion
Recent research has pointed out the important role of
thyroid hormone in the response of the cardiac cell to
ischaemic stress. In fact, excess of thyroid hormone can
result in increased tolerance of the heart against I/R (Buser
et al. 1990, Walker et al. 1995, Liu et al. 1998, Pantos et al.
2000) and PKC and p38 mitogen-activated protein
kinase are suggested to be important elements of this
response (Pantos et al. 2001, 2002a,b). The present study
has explored the possibility that decreased thyroid
Journal of Endocrinology (2003) 178, 427–435
hormone levels could potentially have detrimental effects
on the tolerance of the heart to ischaemia.
An experimental model of hypothyroidism was induced
by administration of propylthiouracil for a period of
3 weeks. This treatment resulted in short-term hypothyroidism with significant but not marked decrease of T4
and T3 levels in plasma. Animal body weight and heart
weight were found to be reduced in HYPO rats whereas
baseline myocardial functional parameters were impaired
in HYPO hearts as compared with NORM. These
findings are consistent with previous reports (Cernohorsky
et al. 1998, Shenoy et al. 2001, Ohga et al. 2002). In fact,
cardiac dysfunction is a common finding in the hypothyroidism and this has been attributed to various changes
that occur in the myocardium (Ohga et al. 2002). Such
changes include increased expression of V3 isomyosin,
reduced expression of SR Ca2+-ATPase and ryanodine
receptor and enhanced expression of phospholamban (Arai
et al. 1991, Kiss et al. 1994, Ohga et al. 2002).
In response to I/R, HYPO hearts displayed an increased post-ischaemic recovery of function as compared
with NORM while ischaemic contracture occurred later
in those hearts. Several studies have concluded similar
results. Abe et al. (1992), using an isolated working heart
model, demonstrated increased recovery of the pressure–
rate product in HYPO hearts as compared with NORM.
Furthermore, Eynan et al. (2002) showed an improved
post-ischaemic recovery of function and delayed ischaemic
contracture in isolated HYPO rat hearts subjected to
zero-flow global ischaemia. Along the same line, Zhang
et al. (2002) have recently demonstrated that hypothyroidism can be protective against I/R arrhythmias.
The mechanisms that underlie hypothyroidism-induced
cardioprotection are not fully understood and changes in
metabolism or energy utilization have been suggested to
be implicated in this effect. In fact, it is thought that
HYPO hearts have a higher efficiency and consume less
oxygen in doing mechanical work due to the predominance of V3 myosin isoform. As a consequence, in HYPO
hearts, ATP levels are found to decline more slowly during
ischaemia and are higher at reperfusion (Abe et al. 1992).
Furthermore, other studies show that pre-ischaemic myocardial glycogen levels are higher in those hearts whereas
glycolysis during ischaemia is slowed (Eynan et al. 2002).
However, it has been recently reported that hearts displaying opposite metabolic characteristics such as hyperthyroid
hearts are also found to be more tolerant to ischaemia
(Buser et al. 1990, Van der Vusse et al. 1998, Pantos et al.
2000, 2001, 2002a,b) indicating that the increased resistance of the HYPO heart to ischaemia cannot be merely
explained on the basis of the metabolic changes that are
observed in those hearts.
It is now realized that intracellular molecules such as
PKC and/or mitogen-activated protein kinases could
play an important role in the adaptive response of the
heart to ischaemia. The role of PKC and its isotypes in
www.endocrinology.org
Hypothyroidism and heart tolerance to ischaemia-reperfusion ·
C PANTOS
and others 431
Figure 2 Ischaemic contracture profiles of normal hearts (NORM) and hearts from hypothyroid
rats (HYPO) subjected to 20 min (upper panel) or 30 min (bottom panel) of ischaemia. (Bar= S.E.M.)
cardioprotection has been demonstrated by various studies
(Speechly-Dick et al. 1994, Kawamura et al. 1998). In fact,
PKC has been shown to be mainly involved in cardioprotective means such as ischaemic preconditioning (Fryer
et al. 2002) while PKC has been implicated in pharmacological preconditioning (Fryer et al. 2001). Interestingly,
chronic T4 administration is shown to upregulate PKC
(Fryer et al. 1998, Pantos et al. 2002a) and induce
pharmacological preconditioning (Pantos et al. 2002a),
while cells overexpressing PKC (Zhao et al. 1998) or
hearts from mice overexpressing PKC are found to be less
susceptible to ischaemia (Cross et al. 2002). In the present
study, PKC expression was found to be increased in
HYPO hearts while PKC expression remained unchanged. On the basis of these data, it could be suggested
that PKC overexpression is likely to be linked to the
increased resistance of those hearts to ischaemia. In support
of this notion is the fact that HYPO hearts closely
resemble hearts from mice overexpressing PKC as regards
www.endocrinology.org
the response to ischaemia as well as ATP utilization during
I/R; in a transgenic model overexpressing PKC in the
myocardium, ATP levels were found to decline more
slowly during ischaemia and to be higher at reperfusion
while post-ischaemic recovery was significantly improved
in those hearts (Cross et al. 2002). Furthermore, PKC
overexpression is also shown to occur in hearts from
diabetic rats that are found to be tolerant to ischaemia and
abnormal thyroid function frequently coexist (Liu et al.
1999).
Recent research has emphasized the important role of
JNK-dependent pathways in determining the response of
the cell against various stresses (Bogoyevitch et al. 1996).
JNKs are found to be activated in stressful conditions and
this has been associated with cell death (Chen et al. 1996)
while inhibition of JNK activation is shown to prevent cell
injury induced by a variety of stresses, including heat
shock, ethanol, UV irradiation, oxidative stress and other
(Gabai et al. 1998). This has been clearly demonstrated in
Journal of Endocrinology (2003) 178, 427–435
432
C PANTOS
and others · Hypothyroidism and heart tolerance to ischaemia-reperfusion
Figure 3 Densitometric assessment of PKC (upper panels) and PKC (bottom panels) expression
in normal hearts (NORM, n=5) and hearts from hypothyroid rats (HYPO, n=5). (Columns are
means of optical ratios, bar= S.E.M.)
Journal of Endocrinology (2003) 178, 427–435
www.endocrinology.org
Hypothyroidism and heart tolerance to ischaemia-reperfusion ·
C PANTOS
and others 433
Figure 4 (Upper panels) Densitometric assessment of phosphorylated JNKs in normal hearts (NORM) and hearts from
hypothyroid rats (HYPO) at baseline (Base, n=5 for each group) and after 20 min of ischaemia and reperfusion (20I/R,
n=5 for each group). (Columns are means of optical ratios, bar= S.E.M.) *P,0·05 vs NORM-Base. (Lower panel)
Western blots showing phosphorylated and total JNKs in NORM and HYPO hearts at baseline (Base, n=5 for each
group) and after 20 min of ischaemia and reperfusion (20I/R, n=5 for each group).
cell-based models by interruption of the JNK signalling
pathway, either immediately upstream of JNK by expression of dominant negative mutants of the JNK activator
SEK1 (Verheij et al. 1996), or immediately downstream of
JNK, by an expression of a dominant negative mutant of
www.endocrinology.org
JNK substrate, c-jun (Gabai et al. 1997). In the present
study, JNKs were found to be significantly activated in
NORM hearts in response to the I/R sequence. In fact,
the levels of phospho-p46 and -p54 JNK after I/R were
found to be 6- and 5-fold more than the baseline values.
Journal of Endocrinology (2003) 178, 427–435
434
C PANTOS
and others · Hypothyroidism and heart tolerance to ischaemia-reperfusion
On the contrary, in HYPO hearts, the levels of phosphop46 and -p54 JNK were not increased after I/R. On the
basis of these data, it seems likely that inhibition of JNK
activation during I/R might be an important element of
HYPO-induced cardioprotection. Several lines of evidence support this notion. Recent studies demonstrate that
in established paradigms of cardioprotection such as ischaemic preconditioning and heat stress pretreatment, JNK
activation is also found to be attenuated during the
subsequent I/R (Sato et al. 2000, Pantos et al. 2003b,c).
The fact that both hypothyroidism and preconditioning
reduce the JNK activation in response to I/R might
indicate that JNK is an essential component of the
protection conferred by these two interventions. It is also
of note that carvedilol administration at reperfusion is
shown to increase tolerance of the heart to ischaemia while
JNK activation is attenuated (Yue et al. 1998).
It appears from this study and from previous studies
that thyroid hormone can play an important role in the
response of the heart to ischaemia. Long-standing alterations in thyroid hormone can induce adaptive changes
in the myocardium with important physiological consequences as regards the cardioprotection. Different
underlying mechanisms seem to exist between the
hypothyroid- and hyperthyroid-induced cardioprotection
and this issue needs to be further investigated.
In conclusion, propylthiouracil-induced hypothyroidism increases post-ischaemic recovery of function and
this was associated with basal PKC overexpression and
attenuated JNK activation in response to I/R.
Acknowledgement
This research has been supported by the Bodosakis
Institution research funds
References
Abe M, Obata H & Tanaka H 1992 Functional and metabolic
responses to ischaemia in the isolated perfused hypothyroid rat
heart. Japanese Circulation Journal 56 671–680.
Arai M, Otsu K, MacLennan DH, Alpert NR & Periasamy M
1991 Effect of thyroid hormone on the expression of mRNA
encoding sarcoplasmic reticulum proteins. Circulation Research 69
266–276.
Bartkowski R, Wojtalik M, Korman E, Sharma G, Henschke J &
Mrowcznski W 2002 Thyroid hormone levels in infants during and
after cardiopulmonary bypass with ultrafiltration. European Journal of
Cardio-thoracic Surgery 22 879–884.
Bogoyevitch M, Gillespie-Brown J, Ketterman A, Fuller S, Ben-Levy
R, Ashworth A, Marshall CJ & Sugden PH 1996 Stimulation of
the stress-activated mitogen-activated protein kinase subfamilies in
perfused heart: p38/RK mitogen-activated protein kinases and
c-jun N-terminal kinases are activated by ischemia/reperfusion.
Circulation Research 79 162–173.
Buser PT, Wikman Coffelt J, Wu ST, Derugin N, Papmley WW &
Higgins CB 1990 Postischemic recovery of mechanical performance
Journal of Endocrinology (2003) 178, 427–435
and energy metabolism in the presence of left ventricular
hypertrophy. A 31P-NMR study. Circulation Research 66 735–746.
Cernohorsky J, Kolar F, Pelouch V, Korecky B & Vetter R 1998
Thyroid control of sarcolemmal Na+/Ca2+ exchanger and SR
Ca2+-ATPase in developing rat heart. American Journal of Physiology
275 H264–H273.
Chen Y-R, Wang X, Templeton D, Davis RJ & Tan T-H 1996 The
role of c-Jun N-terminal kinase (JNK) in apoptosis induced by
ultraviolet C and radiation. Journal of Biological Chemistry 271
31929–31936.
Cross HR, Murphy E, Bolli R, Ping P & Steenbergen C 2002
Expression of activated PKC epsilon (PKC) protects the ischaemic
heart, without attenuating ischaemic H+ production. Journal of
Molecular and Cellular Cardiology 34 361–367.
Eynan M, Knubuvetz T, Meiri U, Navon G, Gerstenblith G,
Bromberg Z, Hasin Y & Horowitz M 2002 Heat acclimationinduced elevated glycogen, glycolysis, and low thyroxine improve
heart ischaemic tolerance. Journal of Applied Physiology 93
2095–2104.
Franklyn JA, Gammage MD, Raymsden DB & Sheppard MC 1984
Thyroid status in patients after acute myocardial infarction. Clinical
Science 67 585–590.
Fryer LGD, Holness MJ, Decock JB & Sugden MC 1998 Cardiac
protein kinase C expression in two models of cardiac hypertrophy
associated with an activated cardiac renin–angiotensin system: effect
of experimental hyperthyroidism and genetic hypertension (the
mRen-2 rat). Journal of Endocrinology 158 27–33.
Fryer R, Wang Y, Hsu A & Gross G 2001 Essential activation of
protein kinase C- in opioid-initiated cardioprotection. American
Journal of Physiology 280 H1346–H1353.
Fryer R, Hsu A, Wang Y, Henry M, Eells J & Gross G 2002 PKC
inhibition does not block preconditioning induced preservation in
mitochodrial ATP synthesis and infarct size reduction in rats. Basic
Research in Cardiology 97 47–54.
Gabai VL, Meriin AB, Mosser DD, Caron AW, Rits S, Shifrin VI &
Sherman MY 1997 Hsp70 prevents activation of stress kinases – a
novel pathway of cellular thermotolerance. Journal of Biological
Chemistry 272 18033–18037.
Gabai VL, Meriin AB, Yaglom JA, Volloch VZ & Sherman MY 1998
Role of Hsp70 in regulation of stress-kinase JNK: implications in
apoptosis and aging. FEBS Letters 438 1–4.
Hak AE, Pols H, Visser TJ, Drexhage HA, Hofman A & Witteman
JCM 2000 Subclinical hypothyroidism is an independent risk factor
for atherosclerosis and myocardial infarction in elderly women: The
Rotterdam Study. Annals of Internal Medicine 132 270–278.
Hamilton MA, Stevenson LW, Foranow GC, Steimle A, Goldhaber JI,
Childs JS, Chopra IJ, Moriguchi JD & Hage A 1998 Safety
and hemodynamic effects of intravenous triiodothyronine in
advanced congestive heart failure. American Journal of Cardiology 81
443–447.
Kawamura S, Yoshida K, Miura T, Mizukami Y & Matsuzaki M
1998 Ischaemic preconditioning translocates PKC- and -, which
mediate functional protection in isolated rat hearts. American Journal
of Physiology 275 H2266–H2271.
Kiss E, Jakab G, Kranias EG & Edes I 1994 Thyroid hormoneinduced alterations in phospholamban protein expression.
Regulatory effects on sarcoplasmic reticulum Ca2+ transport and
myocardial relaxation. Circulation Research 75 245–251.
Klein I & Ojamaa K 2001 Thyroid hormone – targeting the heart.
Endocrinology 142 11–12.
Liu Q, Clanachan AS & Lopaschuk GD 1998 Acute effects of
triiodothyronine on glucose and fatty acid metabolism during
reperfusion of ischemic rat hearts. American Journal of Physiology 275
E392–E399.
Liu X, Wang J, Takeda N, Binaglia L, Panagia V & Dhalla NS 1999
Changes in cardiac protein kinase C activities and isozymes in
streptozotocin-induced diabetes. American Journal of Physiology 277
E798–E804.
www.endocrinology.org
Hypothyroidism and heart tolerance to ischaemia-reperfusion ·
Ohga Y, Sakata S, Takenaka C, Abe T, Tsuji T, Taniguchi S &
Takaki M 2002 Cardiac dysfunction in terms of left ventricular
mechanical work and energetics in hypothyroid rats. American
Journal of Physiology 283 H631–H641.
Pantos C, Mourouzis I, Tzeis S, Malliopoulou V, Cokkinos DD,
Asimakopoulos P, Carageorgiou H, Varonos DD & Cokkinos DV
2000 Propranolol diminishes cardiac hypertrophy but does not
abolish acceleration of the ischemic contracture in hyperthyroid
hearts. Journal of Cardiovascular Pharmacology 36 384–389.
Pantos C, Malliopoulou V, Mourouzis I, Karamanoli E, Tzeis SM,
Carageorgiou H, Varonos D & Cokkinos DV 2001 Long-term
thyroxine administration increases HSP70 mRNA expression and
attenuates p38 MAP kinase activity in response to ischaemia. Journal
of Endocrinology 170 207–215.
Pantos C, Malliopoulou V, Mourouzis I, Karamanoli E, Paizis I,
Steimberg N, Varonos D & Cokkinos DV 2002a Long-term
thyroxine administration protects the heart in a similar pattern as
ischaemic preconditioning. Thyroid 12 325–329.
Pantos C, Mourouzis I, Delbruyere M, Malliopoulou V, Tzeis S,
Cokkinos DD, Nikitas N, Carageorgiou H, Varonos D, Cokkinos
DV et al. 2002b Effects of dronedarone and amiodarone on plasma
thyroid hormones and on the basal and postischemic performance
of the isolated rat heart. European Journal of Pharmacology 444
191–196.
Pantos C, Malliopoulou V, Paizis I, Moraitis P, Mourouzis I, Tzeis S,
Karamanoli E, Cokkinos DD, Carageorgiou H, Varonos D et al.
2003a Thyroid hormone and cardioprotection; study of p38 MAPK
and JNKs during ischaemia and at reperfusion in isolated rat heart.
Molecular and Cellular Biochemistry 242 173–180.
Pantos C, Malliopoulou V, Mourouzis I, Moraitis P, Tzeis S,
Thempeyioti A, Paizis I, Cokkinos AD, Carageorgiou H, Varonos
D et al. 2003b Involvement of p38 MAPK and JNK in the heat
stress-induced cardioprotection. Basic Research in Cardiology 98
158–164.
Pantos C, Mourouzis I, Tzeis S, Moraitis P, Malliopoulou V,
Cokkinos DD, Carageorgiou H, Varonos D & Cokkinos DV
2003c Dobutamine administration exacerbates postischaemic
myocardial dysfunction in isolated rat hearts: an effect reversed by
thyroxine pre-treatment. European Journal of Pharmacology 460
155–161.
www.endocrinology.org
C PANTOS
and others 435
Sato M, Cordis GA, Maulik N & Das DK 2000 SAPKs regulation of
ischaemic preconditioning. American Journal of Physiology 279
H901–H907.
Shenoy R, Klein I & Ojamaa K 2001 Differential regulation of SR
calcium transporters by thyroid hormone in rat atria and ventricles.
American Journal of Physiology 281 H1690–H1696.
Speechly-Dick M, Mocanou M & Yellon D 1994 Protein kinase C:
its role in ischaemic preconditioning in the rat. Circulation Research
75 586–590.
Vanderpump MP & Tunbridge WM 2002 Epidemiology and
prevention of clinical and subclinical hypothyroidism. Thyroid 12
839–847.
Van Der Vusse GJ, Coumans WA, Ulrich M & Van Bilsen M 1998
Thyroxine induced alteration in cardiac energy metabolism. Journal
of Molecular and Cellular Cardiology 30 A110.
Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ,
Szabo E, Zon LI, Kyriakis JM et al. 1996 Requirement for ceramideinitiated SAPK/JNK signalling in stress-induced apoptosis. Nature
380 75–79.
Walker JD, Crawford FA Jr & Spinale FG 1995 3,5,3 Triiodo-thyronine pretreatment with cardioplegic arrest and chronic left
ventricular dysfunction. Annals of Thoracic Surgery 60 292–299.
Walker JM 1994 Basic Protein and Peptide Protocols. Totowa, NJ:
Humana Press.
Yue TL, Ma XL, Gu JL, Ruffolo RR Jr & Feuerstein GZ 1998
Carvedilol inhibits activation of stress-activated protein kinase and
reduces reperfusion injury in perfused rabbit heart. European Journal
of Pharmacology 345 61–65.
Zhang L, Parratt JR, Beastall GH, Pyne NJ & Furman BL 2002
Streptozotocin diabetes protects against arrhythmias in rat isolated
hearts: role of hypothyroidism. European Journal of Pharmacology 435
269–276.
Zhao J, Renner O, Wightman L, Sugden P, Stewart L, Latchman D
& Marber MS 1998 The expression of constitutively active isotypes
of protein kinase C to investigate preconditioning. Journal of
Biological Chemistry 273 23072–23079.
Received 2 March 2003
Accepted 10 June 2003
Journal of Endocrinology (2003) 178, 427–435